Maximum quantity allowed is 999
CAS RN: 54527-84-3 | Product Number: N0635
Nicardipine Hydrochloride

Purity: >98.0%(T)(HPLC)
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
5G |
₹6,600.00
|
4 | ≥80 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | N0635 |
Purity / Analysis Method ![]() |
>98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__2__6H__2__9N__3O__6·HCl = 515.99 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Room Temperature (Recommended in a cool and dark place, <15°C) |
Condition to Avoid | Light Sensitive |
CAS RN | 54527-84-3 |
Related CAS RN ![]() |
55985-32-5 |
Reaxys Registry Number | 4286471 |
PubChem Substance ID | 87573949 |
Merck Index (14) | 6495 |
MDL Number | MFCD00057327 |
Appearance | White to Light yellow to Green powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Solubility in Methanol | almost transparency |
NMR | confirm to structure |
Pictogram |
![]() |
Signal Word | Danger |
Hazard Statements | H301 : Toxic if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
RTECS# | US7972100 |
UN Number | UN2811 |
Class | 6.1 |
Packing Group | III |
References
- Inhibition of calcium influx in rabbit aorta by nicardipine hydrochloride
- Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites
- Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders
- Intravenous nicardipine. Its use in the short-term treatment of hypertension and various other indications (a review)
- Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions
- Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells: correlation of protection with preservation of glutathione levels
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.